{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T23:56:15Z","timestamp":1788134175433,"version":"build-2803163510"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Enzalutamide, a second-generation androgen receptor (AR) pathway inhibitor, is widely used in the treatment of castration-resistant prostate cancer. However, after a period of enzalutamide treatment, patients inevitably develop drug resistance. In this study, we characterized leucine-rich repeated G-protein-coupled receptor 5 (LGR5) and explored its potential therapeutic value in prostate cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A total of 142 pairs of tumor and adjacent formalin-fixed paraf\u00adfin-embedded tissue samples from patients with prostate cancer were collected from the Pathology Department at Sun Yat-sen Memorial Hos\u00adpital. LGR5 was screened by sequencing data of enzalutamide-resistant cell lines combined with sequencing data of lesions with different Gleason scores from the same patients. The biological function of LGR5 and its effect on enzalutamide resistance were investigated\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      . Glutathione-S-transferase (GST) pull-down, coimmunoprecipitation, Western blotting, and immunofluorescence assays were used to explore the specific binding mechanism of LGR5 and related pathway changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      LGR5 was significantly upregulated in prostate cancer and negatively correlated with poor patient prognosis. Overexpression of\n                      <jats:italic toggle=\"yes\">LGR5<\/jats:italic>\n                      promoted the malignant progression of prostate cancer and reduced sensitivity to enzalutamide\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      . LGR5 promoted the phosphorylation of glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) by binding heat shock protein 90,000 alpha B1 (HSP90AB1) and mediated the activation of the Wingless\/integrated (WNT)\/\u03b2-catenin signaling pathway. The increased \u03b2-catenin in the cytoplasm entered the nucleus and bound to the nuclear AR, promoting the transcription level of AR, which led to the enhanced tolerance of prostate cancer to enzalutamide. Reducing HSP90AB1 binding to LGR5 significantly enhanced sensitivity to enzalutamide.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>LGR5 directly binds to HSP90AB1 and mediates GSK-3\u03b2 phosphorylation, promoting AR expression by regulating the WNT\/\u03b2-catenin signaling pathway, thereby conferring resistance to enzalutamide treatment in prostate cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003538","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T23:00:06Z","timestamp":1745622006000},"page":"3184-3194","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["LGR5 interacts with HSP90AB1 to mediate enzalutamide resistance by activating the WNT\/\u03b2-catenin\/AR axis in prostate cancer"],"prefix":"10.1097","volume":"138","author":[{"given":"Ze","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"},{"name":"Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"},{"name":"Department of Urology, Guangzhou First People\u2019s Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510180, China"},{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Urology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 528406, China"},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 528406, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong 510515, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"},{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"},{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"},{"name":"Guangdong Provincial Clinical Research Center for Urological Diseases, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"},{"name":"Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"},{"name":"Guangdong Provincial Clinical Research Center for Urological Diseases, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China"},{"name":"Department of Urology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People\u2019s Hospital, Qingyuan, Guangdong, Guangdong 511518, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"R1-20260303","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R2-20260303","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1097\/CM9.0000000000003442","article-title":"Comparative analysis of cancer statistics in China and the United States in 2024","volume":"24","author":"Wu","year":"2024","journal-title":"Chin Med J"},{"key":"R3-20260303","doi-asserted-by":"crossref","first-page":"188625","DOI":"10.1016\/j.bbcan.2021.188625","article-title":"miRNAs and androgen deprivation therapy for prostate cancer","volume":"1876","author":"Konoshenko","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R4-20260303","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.22.00970","article-title":"Sequencing of androgen-deprivation therapy of short duration with radiotherapy for nonmetastatic prostate cancer (SANDSTORM): A pooled analysis of 12 randomized trials","volume":"41","author":"Ma","year":"2023","journal-title":"J Clin Oncol"},{"key":"R5-20260303","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1200\/JCO.23.00723","article-title":"Early treatment intensification in metastatic hormone-sensitive prostate cancer","volume":"41","author":"Wala","year":"2023","journal-title":"J Clin Oncol"},{"key":"R6-20260303","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.eururo.2023.04.002","article-title":"The efficacy of enzalutamide plus androgen deprivation therapy in oligometastatic hormone-sensitive prostate cancer: A post hoc analysis of ARCHES","volume":"84","author":"Armstrong","year":"2023","journal-title":"Eur Urol"},{"key":"R7-20260303","doi-asserted-by":"crossref","first-page":"100962","DOI":"10.1016\/j.drup.2023.100962","article-title":"Current therapy and drug resistance in metastatic castration-resistant prostate cancer","volume":"68","author":"Cai","year":"2023","journal-title":"Drug Resist Updat"},{"key":"R8-20260303","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/pharmaceutics14030498","article-title":"Choosing kinase inhibitors for androgen deprivation therapy-resistant prostate cancer","volume":"14","author":"Zhong","year":"2022","journal-title":"Pharmaceutics"},{"key":"R9-20260303","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1056\/NEJMoa1800536","article-title":"Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer","volume":"378","author":"Hussain","year":"2018","journal-title":"N Engl J Med"},{"key":"R10-20260303","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1200\/JCO.19.00799","article-title":"ARCHES: A randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer","volume":"37","author":"Armstrong","year":"2019","journal-title":"J Clin Oncol"},{"key":"R11-20260303","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bju.13123","article-title":"Enzalutamide: Targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer","volume":"117","author":"Schalken","year":"2016","journal-title":"BJU Int"},{"key":"R12-20260303","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/14656566.2013.775251","article-title":"Enzalutamide for the treatment of prostate cancer","volume":"14","author":"Pal","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"R13-20260303","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1158\/1078-0432.CCR-16-1357","article-title":"Neoadjuvant enzalutamide prior to prostatectomy","volume":"23","author":"Montgomery","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R14-20260303","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(10)60172-9","article-title":"Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study","volume":"375","author":"Scher","year":"2010","journal-title":"Lancet"},{"key":"R15-20260303","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N Engl J Med"},{"key":"R16-20260303","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41417-021-00332-6","article-title":"Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-resistant prostate cancer","volume":"29","author":"Tang","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"R17-20260303","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2017.07.028","article-title":"Anatomically and functionally distinct lung mesenchymal populations marked by Lgr5 and Lgr6","volume":"170","author":"Lee","year":"2017","journal-title":"Cell"},{"key":"R18-20260303","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2009.11.013","article-title":"Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro","volume":"6","author":"Barker","year":"2010","journal-title":"Cell Stem Cell"},{"key":"R19-20260303","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1053\/j.gastro.2022.07.081","article-title":"Identification of quiescent LGR5(+) stem cells in the human colon","volume":"163","author":"Ishikawa","year":"2022","journal-title":"Gastroenterology"},{"key":"R20-20260303","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"key":"R21-20260303","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.stem.2015.04.013","article-title":"Krt19(+)\/Lgr5(-) cells are radioresistant cancer-initiating stem cells in the colon and intestine","volume":"16","author":"Asfaha","year":"2015","journal-title":"Cell Stem Cell"},{"key":"R22-20260303","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.celrep.2012.12.017","article-title":"Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis","volume":"3","author":"Plaks","year":"2013","journal-title":"Cell Rep"},{"key":"R23-20260303","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.celrep.2012.08.018","article-title":"Lgr5(+ve) stem\/progenitor cells contribute to nephron formation during kidney development","volume":"2","author":"Barker","year":"2012","journal-title":"Cell Rep"},{"key":"R24-20260303","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/ncb3000","article-title":"Lgr5 marks stem\/progenitor cells in ovary and tubal epithelia","volume":"16","author":"Ng","year":"2014","journal-title":"Nat Cell Biol"},{"key":"R25-20260303","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1096\/fj.201900082RR","article-title":"Lgr5-overexpressing mesenchymal stem cells augment fracture healing through regulation of Wnt\/ERK signaling pathways and mitochondrial dynamics","volume":"33","author":"Lin","year":"2019","journal-title":"FASEB J"},{"key":"R26-20260303","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.7150\/thno.30562","article-title":"Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in hepatocellular carcinoma","volume":"9","author":"Ma","year":"2019","journal-title":"Theranostics"},{"key":"R27-20260303","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.5186","article-title":"LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients","volume":"247","author":"Xie","year":"2019","journal-title":"J Pathol"},{"key":"R28-20260303","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13046-018-0864-6","article-title":"LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt\/beta-catenin pathway and predicts poor survival of glioma patients","volume":"37","author":"Zhang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"R29-20260303","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-020-01156-y","article-title":"Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance","volume":"19","author":"Pothuraju","year":"2020","journal-title":"Mol Cancer"},{"key":"R30-20260303","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1158\/1535-7163.MCT-22-0415","article-title":"Loss of LGR5 through therapy-induced downregulation or gene ablation is associated with resistance and enhanced MET-STAT3 signaling in colorectal cancer cells","volume":"22","author":"Posey","year":"2023","journal-title":"Mol Cancer Ther"},{"key":"R31-20260303","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41417-020-00282-5","article-title":"Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model","volume":"28","author":"Tanigawa","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"R32-20260303","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1002\/ctm2.191","article-title":"The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signaling","volume":"10","author":"Li","year":"2020","journal-title":"Clin Transl Med"},{"key":"R33-20260303","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/annonc\/mdv267","article-title":"Treatment of mCRPC in the AR-axis-targeted therapy-resistant state","volume":"26","author":"Chi","year":"2015","journal-title":"Ann Oncol"},{"key":"R34-20260303","doi-asserted-by":"crossref","first-page":"100985","DOI":"10.1016\/j.drup.2023.100985","article-title":"Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells","volume":"70","author":"Wang","year":"2023","journal-title":"Drug Resist Updat"},{"key":"R35-20260303","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12885-021-07913-6","article-title":"LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma","volume":"21","author":"Ehara","year":"2021","journal-title":"BMC Cancer"},{"key":"R36-20260303","doi-asserted-by":"crossref","first-page":"17750","DOI":"10.1038\/s41598-021-97351-y","article-title":"Expression of LGR5 in mammary myoepithelial cells and in triple-negative breast cancers","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"key":"R37-20260303","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12885-020-06986-z","article-title":"LGR5 in breast cancer and ductal carcinoma in situ: A diagnostic and prognostic biomarker and a therapeutic target","volume":"20","author":"Hagerling","year":"2020","journal-title":"BMC Cancer"},{"key":"R38-20260303","doi-asserted-by":"crossref","first-page":"e3039","DOI":"10.1038\/cddis.2017.393","article-title":"LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer","volume":"8","author":"Cao","year":"2017","journal-title":"Cell Death Dis"},{"key":"R39-20260303","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.cell.2022.03.011","article-title":"LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma","volume":"185","author":"Gur","year":"2022","journal-title":"Cell"},{"key":"R40-20260303","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41575-022-00683-x","article-title":"From stem to stern: LGR5(+) as a marker for intestinal crypts","volume":"19","author":"Mohamed","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R41-20260303","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41416-019-0442-5","article-title":"LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer","volume":"120","author":"Nagata","year":"2019","journal-title":"Br J Cancer"},{"key":"R42-20260303","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tcb.2018.01.010","article-title":"Recent advances in Lgr5(+) stem cell research","volume":"28","author":"Leung","year":"2018","journal-title":"Trends Cell Biol"},{"key":"R43-20260303","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.stemcr.2015.04.003","article-title":"Castration-resistant Lgr5(+) cells are long-lived stem cells required for prostatic regeneration","volume":"4","author":"Wang","year":"2015","journal-title":"Stem Cell Reports"},{"key":"R44-20260303","doi-asserted-by":"crossref","first-page":"19530","DOI":"10.1073\/pnas.1908099116","article-title":"Lgr5(+) pericentral hepatocytes are self-maintained in normal liver regeneration and susceptible to hepatocarcinogenesis","volume":"116","author":"Ang","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R45-20260303","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbrc.2011.08.136","article-title":"Hsp90alpha\/beta associates with the GSK3beta\/axin1\/phospho-beta-catenin complex in the human MCF-7 epithelial breast cancer model","volume":"413","author":"Cooper","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"R46-20260303","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.3390\/jcm11216271","article-title":"Maggot extract inhibits cell migration and tumor growth by targeting HSP90AB1 in ovarian cancer","volume":"11","author":"Wang","year":"2022","journal-title":"J Clin Med"},{"key":"R47-20260303","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41419-019-2141-9","article-title":"USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer","volume":"10","author":"Kosinsky","year":"2019","journal-title":"Cell Death Dis"},{"key":"R48-20260303","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7150\/thno.66148","article-title":"Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1\/moesin-mediated inhibition of TGFbeta\/FN1\/CD44 signaling","volume":"12","author":"Sun","year":"2022","journal-title":"Theranostics"},{"key":"R49-20260303","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41388-018-0532-5","article-title":"Hsp90ab1 stabilizes LRP5 to promote epithelial-mesenchymal transition via activating of AKT and Wnt\/beta-catenin signaling pathways in gastric cancer progression","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"key":"R50-20260303","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12967-023-04288-z","article-title":"PARP1 negatively regulates transcription of BLM through its interaction with HSP90AB1 in prostate cancer","volume":"21","author":"Huang","year":"2023","journal-title":"J Transl Med"},{"key":"R51-20260303","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1053\/j.gastro.2023.02.030","article-title":"Stiffness restricts the stemness of the intestinal stem cells and skews their differentiation toward goblet cells","volume":"164","author":"He","year":"2023","journal-title":"Gastroenterology"},{"key":"R52-20260303","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41422-022-00645-7","article-title":"Gut microbiota drives macrophage-dependent self-renewal of intestinal stem cells via niche enteric serotonergic neurons","volume":"32","author":"Zhu","year":"2022","journal-title":"Cell Res"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:00:58Z","timestamp":1772564458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":52,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003538","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"2024-11-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}